We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
-9.52%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.45B
AUM Growth
-$260M
Cap. Flow
-$60.9M
Cap. Flow %
-4.19%
Top 10 Hldgs %
28.63%
Holding
250
New
52
Increased
74
Reduced
49
Closed
70

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$41M
2
AZN icon
AstraZeneca
AZN
+$33.5M
3
PFE icon
Pfizer
PFE
+$33.5M
4
TMUS icon
T-Mobile US
TMUS
+$24.8M
5
FDS icon
Factset
FDS
+$19.9M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$56.1M
2
INFY icon
Infosys
INFY
+$39.4M
3
STX icon
Seagate
STX
+$30.4M
4
DKS icon
Dick's Sporting Goods
DKS
+$30M
5
ACN icon
Accenture
ACN
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Healthcare 16.42%
3 Financials 12%
4 Industrials 11.87%
5 Consumer Staples 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
101
Johnson & Johnson
JNJ
$618B
$1.07M 0.07%
+6,016
New +$1.07M
TD icon
102
Toronto Dominion Bank
TD
$198B
$1.04M 0.07%
15,845
+1,001
+7% +$72.7K
LTHM
103
DELISTED
Livent Corporation
LTHM
$966K 0.07%
+42,586
New +$1.1M
U icon
104
Unity
U
$13.8B
$962K 0.07%
+26,116
New +$1.48M
PGR icon
105
Progressive
PGR
$123B
$959K 0.07%
+8,246
New +$935K
JOBY icon
106
Joby Aviation
JOBY
$7.03B
$933K 0.06%
190,052
-8,343
-4% -$44K
CVX icon
107
Chevron
CVX
$392B
$920K 0.06%
6,357
+93
+1% +$15.4K
GNRC icon
108
Generac Holdings
GNRC
$11.6B
$895K 0.06%
+4,249
New +$1.04M
CVS icon
109
CVS Health
CVS
$133B
$848K 0.06%
+9,147
New +$893K
DUK icon
110
Duke Energy
DUK
$97.8B
$817K 0.06%
7,619
+1,081
+17% +$119K
LIN icon
111
Linde
LIN
$221B
$815K 0.06%
2,836
-45
-2% -$14.1K
RPV icon
112
Invesco S&P 500 Pure Value ETF
RPV
$1.65B
$777K 0.05%
10,344
+739
+8% +$60.6K
AVGO icon
113
Broadcom
AVGO
$1.85T
$772K 0.05%
15,900
+1,930
+14% +$108K
O icon
114
Realty Income
O
$59.6B
$764K 0.05%
+11,196
New +$769K
TMO icon
115
Thermo Fisher Scientific
TMO
$213B
$759K 0.05%
1,397
-14
-1% -$7.71K
CAT icon
116
Caterpillar
CAT
$375B
$754K 0.05%
+4,220
New +$889K
ORLY icon
117
O'Reilly Automotive
ORLY
$72.9B
$732K 0.05%
17,370
-135
-0.8% -$5.81K
RSG icon
118
Republic Services
RSG
$64.8B
$700K 0.05%
5,347
-96
-2% -$12.6K
J icon
119
Jacobs Solutions
J
$15.9B
$696K 0.05%
+6,619
New +$741K
XOM icon
120
ExxonMobil
XOM
$644B
$684K 0.05%
7,990
+2,657
+50% +$240K
LLY icon
121
Eli Lilly
LLY
$1.02T
$683K 0.05%
2,107
+237
+13% +$71.1K
STKL
122
DELISTED
SunOpta
STKL
$664K 0.05%
+85,318
New +$562K
KXI icon
123
iShares Global Consumer Staples ETF
KXI
$1.07B
$628K 0.04%
10,856
+3,059
+39% +$185K
YOU icon
124
Clear Secure
YOU
$5.57B
$605K 0.04%
+30,233
New +$816K
PAVE icon
125
Global X US Infrastructure Development ETF
PAVE
$13.9B
$604K 0.04%
26,522
+5,218
+24% +$134K

Similar funds

Cookson Peirce & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Cookson Peirce & Co held 250 positions worth $1.45B, down 15% from $1.71B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cookson Peirce & Co withdrew a net $60.9M in Q2 2022, closing 70 positions and reducing 49 holdings. Its most notable exit was Infosys, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Cookson Peirce & Co opened a new position in AstraZeneca worth $33.7M.

  • Cookson Peirce & Co's largest Q2 2022 buy was AstraZeneca: 255,164 shares worth $33.7M.
  • Cookson Peirce & Co added most to KLA in Q2 2022, an estimated $41M increase.
  • Cookson Peirce & Co's biggest Q2 2022 reduction was Morgan Stanley, cutting an estimated $56.1M.
  • Cookson Peirce & Co fully exited Infosys in Q2 2022, selling an estimated $39.4M.
  • Cookson Peirce & Co's ten largest holdings make up 29% of its $1.45B portfolio in Q2 2022.
  • Cookson Peirce & Co opened 52 new positions and closed 70 in Q2 2022.
  • Cookson Peirce & Co's portfolio value fell 15% quarter-over-quarter to $1.45B.

Based on Cookson Peirce & Co's 13F filing for Q2 2022, filed 20 Jul 2022.